A recent publication from Heinrich Kovar´s group at St. Anna Children´s Cancer Research Institute (CCRI) and colleagues reveals that inhibition of the YAP/TAZ pathway may prevent Ewing sarcoma cell dissemination and metastasis, thus presenting a promising new therapeutic target for a disease with a long-standing stagnant poor clinical outcome. …
